Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss
Authors:
- Matthew A. WhiteMWMatthew A. White
- Eugene KimEKEugene Kim
- Christopher M. HenstridgeCHChristopher M. Henstridge
- Emiliano Pena AltamiraEAEmiliano Pena Altamira
- Camille K. HuntCHCamille K. Hunt
- Ella BurchillEBElla Burchill
- Andrea LoretoALAndrea Loreto
- Richard MeadRMRichard Mead
- Camilla SimmonsCSCamilla Simmons
Open Access
- 28 October 2019
- journal article
- research article
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 7 (1) , 1-16
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative condition that primarily affects the motor system and shares many features with frontotemporal dementia (FTD). Evidence suggests that ALS is a ‘dying-back’ disease, with peripheral denervation and axonal degeneration occurring before loss of motor neuron cell bodies. Distal to a nerve injury, a similar pattern of axonal degeneration can be seen, which is mediated by an active axon destruction mechanism called Wallerian degeneration. Sterile alpha and TIR motif-containing 1 (Sarm1) is a key gene in the Wallerian pathway and its deletion provides long-term protection against both Wallerian degeneration and Wallerian-like, non-injury induced axonopathy, a retrograde degenerative process that occurs in many neurodegenerative diseases where axonal transport is impaired. Here, we explored whether Sarm1 signalling could be a therapeutic target for ALS by deletingSarm1from a mouse model of ALS-FTD, a TDP-43Q331K, YFP-H double transgenic mouse.Sarm1deletion attenuated motor axon degeneration and neuromuscular junction denervation. Motor neuron cell bodies were also significantly protected. Deletion ofSarm1also attenuated loss of layer V pyramidal neuronal dendritic spines in the primary motor cortex. Structural MRI identified the entorhinal cortex as the most significantly atrophic region, and histological studies confirmed a greater loss of neurons in the entorhinal cortex than in the motor cortex, suggesting a prominent FTD-like pattern of neurodegeneration in this transgenic mouse model. Despite the reduction in neuronal degeneration,Sarm1deletion did not attenuate age-related behavioural deficits caused by TDP-43Q331K. However,Sarm1deletion was associated with a significant increase in the viability of male TDP-43Q331Kmice, suggesting a detrimental role of Wallerian-like pathways in the earliest stages of TDP-43Q331K-mediated neurodegeneration. Collectively, these results indicate that anti-SARM1 strategies have therapeutic potential in ALS-FTD.Keywords
Funding Information
- Motor Neurone Disease Association (Sreedharan/Jan13/943-795)
- Medical Research Council (MR/K010611/1)
- Rosetrees Trust (M799)
- Alzheimer’s Research UK (PG2018B-008)
- Psychiatry Research Trust (PNNTDDR)
This publication has 86 references indexed in Scilit:
- Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosisActa Neuropathologica, 2017
- Neurotrophic Therapy for ALS/MND2014
- Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cordActa Neuropathologica, 2010
- TARDBP mutations in motoneuron disease with frontotemporal lobar degenerationAnnals of Neurology, 2009
- Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxietyPsychopharmacology, 2009
- TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosisBiochemical and Biophysical Research Communications, 2006
- Neuronal intermediate filaments and ALS: A new look at an old questionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changesActa Neuropathologica, 1996
- Axonal swellings in the corticospinal tracts in amyotrophic lateral sclerosisActa Neuropathologica, 1990
- Neurofibrillary axonal swellings and amyotrophic lateral sclerosisJournal of the Neurological Sciences, 1984